The DHRS9 gene is involved in several pathways including the synthesis of allopregnanolone from progesterone. Allopregnanolone is a positive modulator of gamma aminobutyric acid (GABA) action and plays a role in the control of neuronal excitability and seizures. Whole-exome sequencing performed on a girl with an early onset epilepsy revealed that she was a compound heterozygote for two novel missense mutations of the DHRS9 gene likely to disrupt protein function. No previous studies have reported the implication of this gene in epilepsy. We discuss a new potential pathogenic mechanism underlying epilepsy in a child, due to a defective progesterone pathway.
Cali F., Elia M., Vinci M., Vetri L., Correnti E., Trapolino E., et al. (2020). Are mutations in the dhrs9 gene causally linked to epilepsy? A case report. MEDICINA, 56(8), 1-4 [10.3390/medicina56080387].
Are mutations in the dhrs9 gene causally linked to epilepsy? A case report
Vetri L.;Correnti E.;Roccella M.;Romano V.
2020-01-01
Abstract
The DHRS9 gene is involved in several pathways including the synthesis of allopregnanolone from progesterone. Allopregnanolone is a positive modulator of gamma aminobutyric acid (GABA) action and plays a role in the control of neuronal excitability and seizures. Whole-exome sequencing performed on a girl with an early onset epilepsy revealed that she was a compound heterozygote for two novel missense mutations of the DHRS9 gene likely to disrupt protein function. No previous studies have reported the implication of this gene in epilepsy. We discuss a new potential pathogenic mechanism underlying epilepsy in a child, due to a defective progesterone pathway.File | Dimensione | Formato | |
---|---|---|---|
Articolo su mutazione genetica ed epilessia.pdf
accesso aperto
Descrizione: articolo
Tipologia:
Versione Editoriale
Dimensione
404.55 kB
Formato
Adobe PDF
|
404.55 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.